[1]
|
Noone, D.G., Iijima, K. and Parekh, R. (2018) Idiopathic Nephrotic Syndrome in Children. The Lancet, 392, 61-74. https://doi.org/10.1016/s0140-6736(18)30536-1
|
[2]
|
杨帆, 蒋小云. 儿童激素敏感、复发/依赖肾病综合征诊治循证指南(2016)解读[J]. 中华儿科杂志, 2017, 55(10): 738-742.
|
[3]
|
中华医学会儿科学分会肾脏学组. 儿童激素敏感、复发/依赖肾病综合征诊治循证指南(2016) [J]. 中华儿科杂志, 2017, 55(10): 729-734.
|
[4]
|
Rovin, B.H., Adler, S.G., Barratt, J., Bridoux, F., Burdge, K.A., Chan, T.M., et al. (2021) Executive Summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. Kidney International, 100, 753-779. https://doi.org/10.1016/j.kint.2021.05.015
|
[5]
|
Dowerah, P., Gogoi, A., Shira, C.D., et al. (2023) A Study of Dyslipidemia and Its Clinical Implications in Childhood Nephrotic Syndrome. Cureus, 15, e47434. https://doi.org/10.7759/cureus.47434
|
[6]
|
Shatat, I.F., Becton, L.J. and Woroniecki, R.P. (2019) Hypertension in Childhood Nephrotic Syndrome. Frontiers in Pediatrics, 7, Article 287. https://doi.org/10.3389/fped.2019.00287
|
[7]
|
Sarkar, S., Sinha, A., Lakshmy, R., Agarwala, A., Saxena, A., Hari, P., et al. (2016) Ambulatory Blood Pressure Monitoring in Frequently Relapsing Nephrotic Syndrome. The Indian Journal of Pediatrics, 84, 31-35. https://doi.org/10.1007/s12098-016-2207-y
|
[8]
|
罗百文, 邓新强, 温东辉, 等. 儿童原发性肾病综合征血清免疫球蛋白水平的变化分析[J]. 中国医学工程, 2020, 28(1): 56-58.
|
[9]
|
温晓莹, 曾维嘉, 林晓红, 等. 儿童频复发与非频复发型原发单纯型肾病综合征感染特点比较[J]. 现代医院, 2017, 17(7): 1007-1010.
|
[10]
|
Takao, H., Nishi, K., Funaki, T., et al. (2023) Changes in Patterns of Infection Associated with Pediatric Idiopathic Nephrotic Syndrome: A Single-Center Experience in Japan. The Journal of Pediatrics, 254, 11-16. https://doi.org/10.1016/j.jpeds.2022.10.005
|
[11]
|
Guernsey, D., Arun, A., Agha, R. and Kupferman, J.C. (2022) Streptococcus Pneumoniae Meningitis in a Child with Idiopathic Nephrotic Syndrome: A Case Report. Journal of Medical Case Reports, 16, Article No. 403. https://doi.org/10.1186/s13256-022-03648-5
|
[12]
|
Inaba, Y., Miyazono, A., Imadome, K., et al. (2023) A Successful Treatment for Chronic Active Epstein-Barr Virus Disease with Nephrotic Syndrome. CEN Case Reports, 13, 145-148. https://doi.org/10.1007/s13730-023-00815-5
|
[13]
|
Fang, W., Hong, N., Li, Y., et al. (2017) Cryptococcosis in Patients with Nephrotic Syndrome: A Pooled Analysis of Cases. Mycopathologia, 182, 517-525. https://doi.org/10.1007/s11046-016-0101-9
|
[14]
|
Szymanik-Grzelak, H., Kuźma-Mroczkowska, E., Skrzypczyk, P., Bielecka, T., Kotula, I. and Pańczyk-Tomaszewska, M. (2017) Tuberculosis Infection in Children with Proteinuria/Nephrotic Syndrome. Central European Journal of Immunology, 3, 318-323. https://doi.org/10.5114/ceji.2017.70977
|
[15]
|
邢二庆, 王成祥, 尚家星, 等. 儿童肾病综合征并发侵袭性真菌感染危险因素及血清PCT和CRP水平[J]. 中华医院感染学杂志, 2021, 31(13): 1987-1991.
|
[16]
|
Ishikura, K., Matsumoto, S., Sako, M., Tsuruga, K., Nakanishi, K., Kamei, K., et al. (2015) Clinical Practice Guideline for Pediatric Idiopathic Nephrotic Syndrome 2013: Medical Therapy. Clinical and Experimental Nephrology, 19, 6-33. https://doi.org/10.1007/s10157-014-1030-x
|
[17]
|
Iijima, K., Sako, M., Oba, M., Tanaka, S., Hamada, R., Sakai, T., et al. (2022) Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome. Journal of the American Society of Nephrology, 33, 401-419. https://doi.org/10.1681/asn.2021050643
|
[18]
|
Audard, V., Larousserie, F., Grimbert, P., Abtahi, M., Sotto, J., Delmer, A., et al. (2006) Minimal Change Nephrotic Syndrome and Classical Hodgkin’s Lymphoma: Report of 21 Cases and Review of the Literature. Kidney International, 69, 2251-2260. https://doi.org/10.1038/sj.ki.5000341
|
[19]
|
Shalhoub, R. (1974) Pathogenesis of Lipoid Nephrosis: A Disorder of T-Cell Function. The Lancet, 304, 556-560. https://doi.org/10.1016/s0140-6736(74)91880-7
|
[20]
|
Kanai, T., Shiraishi, H., Yamagata, T., Ito, T., Odaka, J., Saito, T., et al. (2010) Th2 Cells Predominate in Idiopathic Steroid-Sensitive Nephrotic Syndrome. Clinical and Experimental Nephrology, 14, 578-583. https://doi.org/10.1007/s10157-010-0330-z
|
[21]
|
张嘉琦, 吴玉秀, 张倩, 等. 儿童激素敏感型肾病综合征频复发因素分析[J]. 中国妇幼健康研究, 2023, 34(5): 73-81.
|
[22]
|
Bhatia, D., Sinha, A., Hari, P., Sopory, S., Saini, S., Puraswani, M., et al. (2018) Rituximab Modulates T-and B-Lymphocyte Subsets and Urinary CD80 Excretion in Patients with Steroid-Dependent Nephrotic Syndrome. Pediatric Research, 84, 520-526. https://doi.org/10.1038/s41390-018-0088-7
|
[23]
|
Shimada, M., Ishimoto, T., Lee, P.Y., Lanaspa, M.A., Rivard, C.J., Roncal-Jimenez, C.A., et al. (2011) Toll-Like Receptor 3 Ligands Induce CD80 Expression in Human Podocytes via an NF-B-Dependent Pathway. Nephrology Dialysis Transplantation, 27, 81-89. https://doi.org/10.1093/ndt/gfr271
|
[24]
|
Colucci, M., Carsetti, R., Serafinelli, J., et al. (2019) Prolonged Impairment of Immunological Memory after Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic Syndrome. Frontiers in Immunology, 10, Article 1653. https://doi.org/10.3389/fimmu.2019.01653
|
[25]
|
于跑, 彭倩倩, 董晨, 等. B淋巴细胞表型在激素依赖及频繁复发肾病综合征患儿的临床意义[J]. 实用医学杂志, 2020, 36(7): 954-958.
|
[26]
|
Kim, Y., Ryu, J., Ryu, M.S., Lim, S., Han, K.O., Lim, I.K., et al. (2014) C-Reactive Protein Induces G2/M Phase Cell Cycle Arrest and Apoptosis in Monocytes through the Upregulation of B-Cell Translocation Gene 2 Expression. FEBS Letters, 588, 625-631. https://doi.org/10.1016/j.febslet.2014.01.008
|
[27]
|
Yildiz, B., Cetin, N., Kural, N., et al. (2013) CD19+ CD23+ B Cells, CD4+ CD25+ T Cells, E-Selectin and Interleukin-12 Levels in Children with Steroid Sensitive Nephrotic Syndrome. Italian Journal of Pediatrics, 39, Article No. 42. https://doi.org/10.1186/1824-7288-39-42
|
[28]
|
Mohamed El Mashad, G., Abd El Hady Ibrahim, S. and Abd Allah Abdelnaby, S. (2017) Immunoglobulin G and M Levels in Childhood Nephrotic Syndrome: Two Centers Egyptian Study. Electronic Physician, 9, 3728-3732. https://doi.org/10.19082/3728
|
[29]
|
王汝琼, 林道炯, 吴守业, 等. 利妥昔单抗对激素依赖型肾病综合征患儿T淋巴细胞亚群和尿CD80水平的影响[J]. 东南大学学报(医学版), 2021, 40(5): 612-617.
|
[30]
|
Gbadegesin, R.A., Adeyemo, A., Webb, N.J.A., Greenbaum, L.A., Abeyagunawardena, A., Thalgahagoda, S., et al. (2015) HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome. Journal of the American Society of Nephrology, 26, 1701-1710. https://doi.org/10.1681/asn.2014030247
|
[31]
|
Kimata, T., Tsuji, S., Kino, J., Kitao, T., Yamanouchi, S. and Kaneko, K. (2012) Close Association between Proteinuria and Regulatory T Cells in Patients with Idiopathic Nephrotic Syndrome. Pediatric Nephrology, 28, 667-669. https://doi.org/10.1007/s00467-012-2387-2
|
[32]
|
Bertelli, R., Bodria, M., Nobile, M., Alloisio, S., Barbieri, R., Montobbio, G., et al. (2011) Regulation of Innate Immunity by the Nucleotide Pathway in Children with Idiopathic Nephrotic Syndrome. Clinical and Experimental Immunology, 166, 55-63. https://doi.org/10.1111/j.1365-2249.2011.04441.x
|
[33]
|
Tsuji, S., Kimata, T., Yamanouchi, S., Kitao, T., Kino, J., Suruda, C., et al. (2017) Regulatory T Cells and CTLA-4 in Idiopathic Nephrotic Syndrome. Pediatrics International, 59, 643-646. https://doi.org/10.1111/ped.13255
|
[34]
|
Li, C., Gao, X., Ni, F., Liu, G. and Jia, S. (2023) Effects of the mTOR Pathway on the Balance of Th2/Treg Cells in Children with Idiopathic Nephrotic Syndrome. Indian Journal of Nephrology, 33, 93-100. https://doi.org/10.4103/ijn.ijn_521_21
|
[35]
|
Li, Y.Y., Wei, S.G., Zhao, X., et al. (2016) Th17/Treg Cell Expression in Children with Primary Nephritic Syndrome and the Effects of Ox-LDL on Th17/Treg Cells. Genetics and Molecular Research, 15, 1-8. https://doi.org/10.4238/gmr.15027669
|
[36]
|
Shao, X.S., Yang, X.Q., Zhao, X.D., Li, Q., Xie, Y.Y., Wang, X.G., et al. (2009) The Prevalence of Th17 Cells and FOXP3 Regulate T Cells (Treg) in Children with Primary Nephrotic Syndrome. Pediatric Nephrology, 24, 1683-1690. https://doi.org/10.1007/s00467-009-1194-x
|
[37]
|
Akilesh, S., Huber, T.B., Wu, H., Wang, G., Hartleben, B., Kopp, J.B., et al. (2008) Podocytes Use FcRn to Clear IgG from the Glomerular Basement Membrane. Proceedings of the National Academy of Sciences, 105, 967-972. https://doi.org/10.1073/pnas.0711515105
|
[38]
|
Reiser, J. and Mundel, P. (2004) Danger Signaling by Glomerular Podocytes Defines a Novel Function of Inducible B7-1 in the Pathogenesis of Nephrotic Syndrome. Journal of the American Society of Nephrology, 15, 2246-2248. https://doi.org/10.1097/01.asn.0000136312.46464.33
|
[39]
|
Garin, E.H., Diaz, L.N., Mu, W., Wasserfall, C., Araya, C., Segal, M., et al. (2009) Urinary CD80 Excretion Increases in Idiopathic Minimal-Change Disease. Journal of the American Society of Nephrology, 20, 260-266. https://doi.org/10.1681/asn.2007080836
|
[40]
|
Fornoni, A., Sageshima, J., Wei, C., et al. (2011) Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis. Science Translational Medicine, 3, 85ra46. https://doi.org/10.1126/scitranslmed.3002231
|
[41]
|
Kaya, M., Girişgen, İ., Yalçın, N., Becerir, T., Şenol, H., Gülten, G., et al. (2023) The Importance of Sphingomyelin Phosphodiesterase Acid-Like 3b (SMPDL-3b) Levels in Kidney Biopsy Specimens of Children with Nephrotic Syndrome. Fetal and Pediatric Pathology, 42, 936-949. https://doi.org/10.1080/15513815.2023.2267683
|
[42]
|
Takahashi, Y., Ikezumi, Y. and Saitoh, A. (2016) Rituximab Protects Podocytes and Exerts Anti-Proteinuric Effects in Rat Adriamycin-Induced Nephropathy Independent of B-Lymphocytes. Nephrology, 22, 49-57. https://doi.org/10.1111/nep.12737
|
[43]
|
Watanabe, S., Hirono, K., Aizawa, T., Tsugawa, K., Joh, K., Imaizumi, T., et al. (2020) Podocyte Sphingomyelin Phosphodiesterase Acid-Like 3b Decreases among Children with Idiopathic Nephrotic Syndrome. Clinical and Experimental Nephrology, 25, 44-51. https://doi.org/10.1007/s10157-020-01970-0
|
[44]
|
李月兰. 他克莫司治疗儿童激素依赖型和耐药型肾病综合征的疗效比较[J]. 实用临床医药杂志, 2016, 20(7): 109-112.
|
[45]
|
Ulinski, T. and Aoun, B. (2010) Pediatric Idiopathic Nephrotic Syndrome: Treatment Strategies in Steroid Dependent and Steroid Resistant Forms. Current Medicinal Chemistry, 17, 847-853. https://doi.org/10.2174/092986710790712174
|
[46]
|
Gellermann, J., Weber, L., Pape, L., Tönshoff, B., Hoyer, P. and Querfeld, U. (2013) Mycophenolate Mofetil versus Cyclosporin A in Children with Frequently Relapsing Nephrotic Syndrome. Journal of the American Society of Nephrology, 24, 1689-1697. https://doi.org/10.1681/asn.2012121200
|
[47]
|
Dorresteijn, E.M., Kist-van Holthe, J.E., Levtchenko, E.N., Nauta, J., Hop, W.C.J. and van der Heijden, A.J. (2008) Mycophenolate Mofetil versus Cyclosporine for Remission Maintenance in Nephrotic Syndrome. Pediatric Nephrology, 23, 2013-2020. https://doi.org/10.1007/s00467-008-0899-6
|
[48]
|
许云鹏, 郭艳芳. 儿童难治性肾病综合征的治疗进展[J]. 中华临床医师杂志(电子版), 2014, 8(23): 4270-4273.
|
[49]
|
Cammas, B., Harambat, J., Bertholet-Thomas, A., Bouissou, F., Morin, D., Guigonis, V., et al. (2010) Long-Term Effects of Cyclophosphamide Therapy in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome. Nephrology Dialysis Transplantation, 26, 178-184. https://doi.org/10.1093/ndt/gfq405
|
[50]
|
余涛. 小儿激素依赖型肾病综合征应用长春新碱与环磷酰胺治疗的效果比较[J]. 河南医学研究, 2014, 23(10): 62-63.
|
[51]
|
Couderc, A., Bérard, E., Guigonis, V., Vrillon, I., Hogan, J., Audard, V., et al. (2017) Traitements du syndrome néphrotique cortico-dépendant de l’enfant. Archives de Pédiatrie, 24, 1312-1320. https://doi.org/10.1016/j.arcped.2017.09.002
|
[52]
|
Iijima, K., Sako, M., Nozu, K., Mori, R., Tuchida, N., Kamei, K., et al. (2014) Rituximab for Childhood-Onset, Complicated, Frequently Relapsing Nephrotic Syndrome or Steroid-Dependent Nephrotic Syndrome: A Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial. The Lancet, 384, 1273-1281. https://doi.org/10.1016/s0140-6736(14)60541-9
|
[53]
|
Basu, B., Sander, A., Roy, B., Preussler, S., Barua, S., Mahapatra, T.K.S., et al. (2018) Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome. JAMA Pediatrics, 172, 757-764. https://doi.org/10.1001/jamapediatrics.2018.1323
|
[54]
|
Bonanni, A., Rossi, R., Murtas, C., et al. (2015) Low-Dose Ofatumumab for Rituximab-Resistant Nephrotic Syndrome. BMJ Case Reports, 2015. https://doi.org/10.1136/bcr-2015-210208
|
[55]
|
Wang, C., Liverman, R.S., Garro, R., George, R.P., Glumova, A., Karp, A., et al. (2017) Ofatumumab for the Treatment of Childhood Nephrotic Syndrome. Pediatric Nephrology, 32, 835-841. https://doi.org/10.1007/s00467-017-3621-8
|
[56]
|
Vivarelli, M., Colucci, M., Bonanni, A., Verzani, M., Serafinelli, J., Emma, F., et al. (2016) Ofatumumab in Two Pediatric Nephrotic Syndrome Patients Allergic to Rituximab. Pediatric Nephrology, 32, 181-184. https://doi.org/10.1007/s00467-016-3498-y
|
[57]
|
Dossier, C., Prim, B., Moreau, C., Kwon, T., Maisin, A., Nathanson, S., et al. (2020) A Global Antib Cell Strategy Combining Obinutuzumab and Daratumumab in Severe Pediatric Nephrotic Syndrome. Pediatric Nephrology, 36, 1175-1182. https://doi.org/10.1007/s00467-020-04811-0
|
[58]
|
Dossier, C., Bonneric, S., Baudouin, V., Kwon, T., Prim, B., Cambier, A., et al. (2023) Obinutuzumab in Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome in Children. Clinical Journal of the American Society of Nephrology, 18, 1555-1562. https://doi.org/10.2215/cjn.0000000000000288
|